The first vaccine trial against Bundibugyo Ebola began in Bunia as the DR Congo outbreak passed 9,700 cases and 4,600 deaths
WHO Director-General Tedros Adhanom Ghebreyesus said on 24 October that the first participants in the Tumaini ring-vaccination trial had been vaccinated in Bunia, Ituri province, starting with Merck's Ervebo, which is licensed only against the Zaire species; Bundibugyo-specific candidates from the University of Oxford and Moderna are to be added. The outbreak, declared in May, is the second-largest on record and has spread to four countries.
why it mattersNo vaccine is yet shown to work against this species, so plan for the outbreak, and the screening and travel measures around East and Central Africa, to keep widening until the trial reports rather than taper.